From: Proton beam therapy for hepatocellular carcinoma with bile duct invasion
Basic characteristics | Â |
Age (years), median [IQR] | 71 [63.5, 79.0] |
Sex (Male / Female) | 12 (80.0%) / 3 (20.0%) |
Performance status score (0 / 1–3) | 6 (40.0%) / 9 (60.0%) |
Child (A / B,C) | 8 (53.3%) / 7 (46.7%) |
Etiology (HBV / HCV / NBNC) | 2 (13.4%) / 8 (53.3%) / 5 (33.3%) |
Tumor characteristics | Â |
Size, median [IQR], cm | 4.0 [3.4–6.3] |
Number (Solitary / Multiple) | 11 (73.3%) / 4 (26.7%) |
Prior treatment history (No / Yes) | 7 (46.7%) / 8 (53.3%) |
Type of BDI (Central / Peripheral) | 11 (73.3%) / 4 (26.7%) |
BDTT (No / Yes) | 2 (13.3%) / 13 (86.7%) |
AFP, median [IQR], ng/ml | 57.0 [15.7, 350.2] |
DCP, median [IQR], mAU/ml | 45 [17.0, 612.0] |